ImmunityBio Inc.

NASDAQ: IBRX · Real-Time Price · USD
2.61
-0.10 (-3.69%)
At close: Aug 15, 2025, 11:37 AM

ImmunityBio Revenue

ImmunityBio reported an annual revenue of $14.74M, reflecting a 2270.58% growth. For the quarter ending June 30, 2025, ImmunityBio generated $26.43M in revenue.
Revenue (ttm)
14.74M
Revenue Growth
2270.58%
Price / Sales Ratio
121.07
Revenue / Employee
21.97K
Employees
671
Market Cap
2.46B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.